3 Reasons Investors Love United Therapeutics (UTHR)

Since April 2021, the S&P 500 has delivered a total return of 68.6%. But one standout stock has more than doubled the market - over the past five years, United Therapeutics has surged 186% to $583.82 per share. Its momentum hasn’t stopped as it’s also gained 34.7% in the last six months, beating the S&P by 29.4%.